All In Biotech

Free tool

FAERS Monitor: Cerezyme

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 020367 or its brand name (Cerezyme, Imiglucerase). Reports on generic versions are filed under their own applications.

Reports

4,775

Serious

3,317

69% of reports

Hospitalization

1,476

Death reported

821

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pyrexia216
  • fatigue192
  • death174
  • fall174
  • pneumonia174
  • weight increased163
  • exposure during pregnancy162
  • dyspnoea151
  • bone pain150
  • weight decreased140
  • malaise137
  • arthralgia130
  • disease progression129
  • pain123
  • condition aggravated117

Reports by year received

View as table
YearReports
2004115
2005105
2006123
2007164
2008170
2009233
2010225
2011262
2012172
2013230
2014386
2015273
2016226
2017277
2018213
2019202
2020146
2021201
2022225
2023213
2024196
2025226
2026192

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,384 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
exposure during pregnancySignal16211.59.91,545
bone painSignal15011.39.71,399
disease progressionSignal1294.84.1387
weight increasedSignal1633.22.8248
pyrexiaSignal2162.82.4243
pneumoniaSignal1742.42.0138
fallSignal1742.32.0129
weight decreasedSignal1402.21.993
condition aggravated1171.71.433
arthralgia1301.41.213
malaise1371.41.214
dyspnoea1511.21.04
fatigue1921.10.91
death1740.90.82
pain1230.90.72

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.